Table 4 Clinical and biochemical parameters at baseline and end of study
Baseline (n=15) | End of Study (n=15) | ||||
|---|---|---|---|---|---|
Mean ± SD | Mean ± SD | P | |||
Age (years) | 57.9 ± 11.1 | ||||
Gender (male/female) | (8/7) | ||||
Body weight (kg) | 72.0 ± 10.9 | 71.7 ± 10.9 | 0.12 | ||
BMI | 24.9 ± 2.4 | 24.8 ± 2.4 | 0.11 | ||
leukocytes (109/l) | 5.93 ± 1.63 | 5.63 ± 1.62 | 0.306 | ||
hemoglobin (g/l) | 143.5 ± 9.9 | 140.2 ± 10.2 | 0.066 | ||
hematocrit (%) | 43.9 ± 2.7 | 42.8 ± 3.0 | 0.066 | ||
erythrocytes (1012/l) | 4.83 ± 0.37 | 4.66 ± 0.46 | 0.014 | ||
creatinine (μmol/l) | 69.1 ± 10.9 | 69.7 ± 8.7 | 0.681 | ||
gamma-glutamyl transferase (U/l) | 17.0 ± 5.6 | 14.8 ± 5.8 | 0.017 | ||